Package 68071-2287-4

{"route": ["ORAL"], "spl_id": "1d783899-ed3d-bf0a-e063-6394a90ade17", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0368071228748"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["b2ae0432-bd2a-1480-e053-2a95a90a6fc8"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET in 1 BOTTLE (68071-2287-4)", "package_ndc": "68071-2287-4", "marketing_end_date": "20261231", "marketing_start_date": "20201027"}], "brand_name": "acyclovir", "product_id": "68071-2287_1d783899-ed3d-bf0a-e063-6394a90ade17", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68071-2287", "generic_name": "acyclovir", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA077309", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20070609"}